Company
Headquarters: Tokyo, Japan
Employees: 330
CEO: Hiroshi Shibasaki
¥9.90 Billion
JPY as of July 1, 2025
US$69.0 Million
Company | Market Cap (USD) |
---|---|
Abbott | $233.33 B |
Boston Scientific Corporation | $154.34 B |
Stryker | $151.06 B |
Medtronic | $113.25 B |
Edwards Lifesciences Corporation | $45.05 B |
Company | Market Cap (USD) |
---|---|
Lilly | $699.59 B |
Johnson & Johnson | $374.29 B |
AbbVie | $336.94 B |
Novo Nordisk | $309.91 B |
UnitedHealth Group | $279.90 B |
DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.
DVx, Inc. has the following listings and related stock indices.
Stock: JPX: 3079 wb_incandescent